Will Eric Lefkofsky Defeat Cancer Once And For All?

A Billionaire On A Mission

Eric Lefkofsky is a man on a mission. After amassing a billion dollar fortune through the success of startups he has either founded or invested money in, he is now trying to fight one of the world’s most lethal diseases. Cancer, and the many forms it comes in, is one of the most common causes of death, but the current treatment paradigm simply isn’t able to handle the disease without producing many side effects for patients. Tempus, the startup Eric Lefkofsky has created, aims to solve this problem with the use of Big Data.

The Age Of Personalized Medicine

Tempus is only the latest company advancing the trend of personalized medicine. Personalized medicine, medical care tailored around the specific details of a patient’s profile, is currently taking off thanks to improve DNA databases and Big Data analytics. Armed with the DNA sequence of a patient physicians can then determine which route of treatment is best suited for each patient. Some genes work well with certain treatments, but others will notice no impact or undesirable side effects thanks to their DNA. An example of this personalized medicine at work is immunotherapy. Using the DNA sequence of patients, Tempus determines which patients are best suited for immunotherapy treatments. Some patients are able to handle the process well, but there are always cases of patients who simply lack an immune system prepared for it.

The Complicated Case Of Cancer

Tempus isn’t just taking on any disease out there. Lefkofsky has a specific goal of defeating cancer in mind. Tempus may have access to some of the most sophisticated analytics around, but the task before them is hardly an easy one. Cancer is more than a collection of genetic or environmental factors. Breast cancer, an example of a common cancer, is considered partially genetic. There are even some researchers who believe the cancer is almost “random” with no real path to cures possible. If there’s anything to the genomic sequencing and transcriptomic sequencing of Tempus, this will bear out in patient testimonies.

Only Time Can Tell

Predicting the future is a complicated thing. To create a reliable understanding of exactly how things will play out in the future every possible bit of data is necessary. Fortunately, Eric Lefkofsky is up to the task. As an entrepreneur, he has made a fortune speculating about which companies would eventually turn into winners and which ones he should avoid. Pouring his energy into Tempus shows that Lefkofsky believes he has picked a market winner. While Lefkofsky has certainly set a very serious goal for himself, he is in a better position than anyone else to see it through.

Leave a Reply

Your email address will not be published. Required fields are marked *